BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36089919)

  • 1. One-Year Incidences of Venous Thromboembolism, Bleeding, and Death in Patients With Lung Cancer (Cancer-VTE Subanalysis).
    Awano N; Okano T; Kawachi R; Matsumoto M; Kimura T; Takita A; Oba MS; Kunitoh H
    JTO Clin Res Rep; 2022 Sep; 3(9):100392. PubMed ID: 36089919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism in Japanese patients with breast cancer: subgroup analysis of the Cancer-VTE Registry.
    Ohsumi S; Watanabe K; Kondo N; Kosaka Y; Ishikawa T; Kitahara M; Kubo S; Oba MS; Kimura T; Takita A; Mukai H
    Breast Cancer; 2023 Jul; 30(4):607-616. PubMed ID: 37069366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry pancreatic cancer subcohort.
    Okusaka T; Saiura A; Shimada K; Ikeda M; Ioka T; Kimura T; Hosokawa J; Takita A; Oba MS
    J Gastroenterol; 2023 Dec; 58(12):1261-1271. PubMed ID: 37676492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort.
    Yoshikawa T; Sano T; Terashima M; Yamaguchi K; Bando E; Kawabata R; Yabusaki H; Shinohara H; Oba MS; Kimura T; Takita A; Sasako M
    Gastric Cancer; 2023 Jul; 26(4):493-503. PubMed ID: 37004667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer-VTE Registry).
    Ikeda M; Uetake H; Yoshino T; Hata T; Oba MS; Takita A; Kimura T
    Cancer Sci; 2022 Nov; 113(11):3901-3911. PubMed ID: 35947508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis.
    Nakamura M; Sakon M; Sasako M; Okusaka T; Mukai H; Fujiwara K; Kunitoh H; Oba MS; Wada H; Hosokawa J; Takita A; Ikeda M
    Int J Clin Oncol; 2024 Apr; 29(4):407-416. PubMed ID: 38430303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry.
    Ohashi Y; Ikeda M; Kunitoh H; Sasako M; Okusaka T; Mukai H; Fujiwara K; Nakamura M; Oba MS; Kimura T; Ibusuki K; Takita A; Sakon M
    Thromb Res; 2022 May; 213():203-213. PubMed ID: 35282898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in patients with cancer: design and rationale of a multicentre, prospective registry (Cancer-VTE Registry).
    Ohashi Y; Ikeda M; Kunitoh H; Sasako M; Okusaka T; Mukai H; Fujiwara K; Nakamura M; Kimura T; Ibusuki K; Sakon M
    BMJ Open; 2018 May; 8(5):e018910. PubMed ID: 29848769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY; Kamphuisen PW; Meyer G; Bauersachs R; Janas MS; Jarner MF; Khorana AA;
    JAMA; 2015 Aug; 314(7):677-686. PubMed ID: 26284719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, clinical characteristics and long-term prognosis of postoperative symptomatic venous thromboembolism: a retrospective cohort study.
    Takeda C; Yamashita Y; Takeuchi M; Yonekura H; Dong L; Hamada M; Hirotsu A; Ono K; Kawakami K; Fukuda K; Morimoto T; Kimura T; Mizota T
    BMJ Open; 2022 Feb; 12(2):e055090. PubMed ID: 35173005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and impact of screening for venous thromboembolism in treatment-naive lung cancer patients-Results of a prospective cohort study.
    Muthu V; Narasimhan RL; Prasad KT; Ahluwalia J; Garg M; Behera D; Singh N
    Indian J Cancer; 2022; 59(2):203-211. PubMed ID: 33753627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Study on Efficacy and Safety of Rivaroxaban and Dalteparin for Long-Term Treatment of Venous Thromboembolism in Patients with Lung Cancer.
    Lee JH; Hyun DG; Choi CM; Lee JC; Kim WS; Oh YM; Lee SD; Lee JS
    Respiration; 2019; 98(3):203-211. PubMed ID: 31096241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Spirk D; Sebastian T; Barco S; Banyai M; Beer JH; Mazzolai L; Baldi T; Aujesky D; Hayoz D; Engelberger RP; Kaeslin T; Korte W; Escher R; Husmann M; Blondon M; Kucher N
    Thromb Haemost; 2021 May; 121(5):641-649. PubMed ID: 33202448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could venous thromboembolism and major bleeding be indicators of lung cancer mortality? A nationwide database study.
    Howlett J; Benzenine E; Cottenet J; Foucher P; Fagnoni P; Quantin C
    BMC Cancer; 2020 May; 20(1):461. PubMed ID: 32448219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK).
    Kuderer NM; Poniewierski MS; Culakova E; Lyman GH; Khorana AA; Pabinger I; Agnelli G; Liebman HA; Vicaut E; Meyer G; Shepherd FA
    Oncologist; 2018 Feb; 23(2):247-255. PubMed ID: 28951500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation Therapy for Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.
    Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Konishi T; Akao M; Kobayashi Y; Inoue T; Oi M; Izumi T; Takahashi K; Tada T; Chen PM; Murata K; Tsuyuki Y; Sakai H; Saga S; Sasa T; Sakamoto J; Yamada C; Kinoshita M; Togi K; Ikeda T; Ishii K; Kaneda K; Mabuchi H; Otani H; Takabayashi K; Takahashi M; Shiomi H; Makiyama T; Ono K; Kimura T;
    Circ J; 2018 Apr; 82(5):1262-1270. PubMed ID: 29576597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism: Insights From the Hokusai-VTE Cancer Study.
    Farmakis IT; Barco S; Mavromanoli AC; Konstantinides SV; Valerio L
    JACC CardioOncol; 2022 Nov; 4(4):507-518. PubMed ID: 36444229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of incidental venous thromboembolism in cancer patients.
    Mulder FI; Di Nisio M; Ay C; Carrier M; Bosch FTM; Segers A; Kraaijpoel N; Grosso MA; Zhang G; Verhamme P; Wang TF; Weitz JI; Middeldorp S; Raskob G; Beenen LFM; Büller HR; van Es N
    Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31727694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-Associated Venous Thromboembolism in the Real World - From the COMMAND VTE Registry.
    Sakamoto J; Yamashita Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Izumi T; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Nishimoto Y; Sasa T; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Yoshikawa Y; Shiomi H; Kato T; Makiyama T; Ono K; Tamura T; Nakagawa Y; Kimura T;
    Circ J; 2019 Oct; 83(11):2271-2281. PubMed ID: 31548438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.